LGS technology

NewsFlash: Animas Vibe Finally Submitted to FDA!

By MikeH on April 16, 2013

When exactly the Animas Vibe integrated insulin pump and continuous glucose monitor (CGM) hits the U.S. market is now up to the FDA.
Almost two years after the Animas Vibe hit the market in Europe, this Monday Johnson & Johnson submitted the pump to the U.S. regulatory agency. The company publicly announced the submission during their first quarter earnings call early this morning.
Our Diabetes Community has been anxiously awaiting this news since October, when…

Read more »

Animas’ Hypo-Hyper Minimizer Aims for Diabetes “Cruise Control”

By MikeH on March 19, 2013

Snuggled up in my bed under the warm covers, all I want to do is keep my eyes closed.
But, no. My darn insulin pump and continuous glucose monitor (CGM) just won’t shut up and let me sleep. Both vibrate and beep incessantly, reminding me that I’m low and nagging me to wake up and do something about it.
Neither device can actually intervene or do anything to prevent these lows (or highs) from happening.…

Read more »

Grappling with FDA Over Low-Glucose Suspend

By AmyT on September 27, 2011

Wondering why all the latest and greatest diabetes technology seems to get launched only in Europe these days? Wait, it gets worse…
Did you know that 40 different countries around the world have approved new Low-Glucose Suspend (LGS) technology — which allows a CGMS-augmented insulin pump to automatically shut off basal insulin when it detects a BG reading below the target range, an amazing safety feature! — yet FDA is still not anywhere close to being…

Read more »